Prescribing
16 results
Applied filters
Continuing management of the ADHD medicines shortage
16 November 2023Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).
Prescribing and switching between modified-release methylphenidate
16 November 2023Modified-release methylphenidate capsules and tablets differ. Ensure patients receive appropriate treatment, particularly during periods of supply disruption.
Prescribing available medicines to treat ADHD
27 September 2023The availability of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD) varies currently. Supply content is maintained regularly by DHSC.
Prescribing GLP-1 receptor agonists
28 June 2023Glucagon-like peptide-1 (GLP-1) receptor agonist availability is resolved. Supply content is maintained by DHSC.
Example medicines to prescribe by brand name in primary care
27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Prescribing by generic or brand name in primary care
27 March 2022Prescribing medicines by generic name is generally preferred but there are some circumstances when brand-name prescribing is warranted.